Use of gadopentetate dimeglumine as a contrast agent for percutaneous transluminal renal angioplasty and stent placement

Kidney International

Volumn 53, Issue 2, 1998, Pages 503-507

  Spinosa, David J ^a   Matsumoto, Alan H ^a   Angle, J Fritz ^a   Hagspiel, Klaus D ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

Angioplasty; Contrast agent; Gadopentetate dimeglumine; Renal artery stenosis; Stent placement

Indexed keywords

CARBON DIOXIDE; CONTRAST MEDIUM; GADOLINIUM PENTETATE; GADOLINIUM PENTETATE MEGLUMINE;

AGED; ARTICLE; BALLOON CATHETER; CASE REPORT; DIGITAL SUBTRACTION ANGIOGRAPHY; HUMAN; INTRAARTERIAL DRUG ADMINISTRATION; KIDNEY ARTERY STENOSIS; KIDNEY FAILURE; MALE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; STENT;

EID: 0031951560     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1998.00764.x     Document Type: Article

References (16)

1. HALLETT JW JR, FOWL R, O'BRIEN PC, BERNATZ PE, PAIROLERO PC, CHERRY KJ JR, HOLLIER LH: Renovascular operations in patients with chronic renal insufficiency: Do the benefits justify the risks? J Vascular Surg 5:622-227, 1987
2. TEGTMEYER CJ, MATSUMOTO AH, JOHNSON AM: Renal angioplasty, in Abrams Angiography Interventional Radiology, edited by BAUM S, PENTECOST MJ, Boston, Little, Brown and Company, 1997, pp 294-325
3. PRINCE MR, ARNOLDUS C, FRISOLI JK: Nephrotoxicity of high-dose gadolinium compared with iodinated contrast. JMRI 6:162-166, 1996
4. HAUSTEIN J, NIENDORF HP, KRESTIN G, LOUTON T, SCHUHMANN-GIAMPIERI G, CLAUSS W, JUNGE W: Renal tolerance of gadolinium-DTPA/dimeglumine in patients with chronic renal failure. Invest Radiol 27:153-156, 1992
5. KINNO Y, ODAGIRI K, ANDOH K, ITOH Y, TARAO K: Gadopentetate dimeglumine as an alternative contrast material for use in angiography. Am J Roentgenol 160:1293-1294, 1993
6. FOBBE F, WACKER F, WAGNER S: Arterial angiography in high kilovoltage technique with gadolinium as the contrast agent. First clinical experience. Eur Radiol 6:224-229, 1996
7. KAUFMAN JA, GELLER SC, WALTMAN AC: Renal insufficiency: Gadopentetate dimeglumine as a radiographic contrast agent during peripheral vascular interventional procedures. Radiology 198:579-581, 1996
8. KATZBERG RW: New and old contrast agents: Physiology and nephrotoxicity. Urol Rad 10:6-11, 1988
9. BYRD L, SHERMAN RL: Radiocontrast induced acute renal failure: A clinical and pathophysiologic review. Medicine (Baltimore) 58:270-279, 1979
10. BERNS AS: Nephrotoxicity of contrast material. Kidney Int 36:730-740, 1989
11. HOGSTROM B, KRISTOFFERSEN DT, LUNDBY B, SVALAND MG: Safety of gadodiamide injection in two different age groups. J Magn Reson Imaging 1:255-257, 1996
12. NIENDORF HP, HAUSTEIN J, LOUTON T, BECK W, LANIADO M: Safety and tolerance after intravenous administration of 0.3 mmol/kg Gd-DTPA. Results of a randomized, controlled clinical trial. Invest Radiol 26(Suppl 1):S221-S223, 1991
13. GOLDSTEIN HA, KASHANIAN FK, BLUMETTI RF, HOLYOAK WL, HUGO FP, BLUMENFIELD DM: Safety assessment of gadopentetate dimeglumine in US clinical trials. Radiology 174:17-23, 1990
14. ROFSKY NM, WEINREB JC, BOSNIAK MA, LIBES RB, BIRNBAUM BA: Renal lesion characterization with gadolinium-enhanced MR imaging: Efficacy and safety in patients with renal insufficiency. Radiology 180:85-89, 1991
15. CACHERIS WP, QUAY SC, ROCKLAGE SM: The relationship between thermodynamics and the toxicity of gadolinium complexes. Magnet Res Imag 8:467-481, 1990
16. HAWKINS IF, CURAN SR: Carbon dioxide digital subtraction angiography, in Current Techniques in Interventional Radiology, edited by COPE C, Philadelphia, Current Medicine, 1994, pp 11.1-11.17